Harbin Gloria Pharmaceuticals Co., Ltd (002437.SZ)

CNY 2.69

(-0.74%)

Market Cap (In CNY)

5.89 Billion

Revenue (In CNY)

2.58 Billion

Net Income (In CNY)

120.33 Million

Avg. Volume

35.3 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.66-2.99
PE
-
EPS
-
Beta Value
0.419
ISIN
CNE100000QG8
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Leifeng Guo
Employee Count
-
Website
https://www.gloria.cc
Ipo Date
2011-10-27
Details
Harbin Gloria Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products primarily in the People's Republic of China. It offers cardiac cerebrovascular medication, skeletal muscle system, vitamins and minerals, urinary system medication, antitumor medication, endocrine medicine, anti-infective drugs, respiratory medication, antihistamine, peptic, and other products. Harbin Gloria Pharmaceuticals Co., Ltd. was founded in 2000 and is based in Harbin, the People's Republic of China.